Compare, Analyse Cipla with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs TEVA PHARMA (Israel) - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   TEVA PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-19
TEVA PHARMA
Dec-13
CIPLA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6783,075-   
Low Rs4842,671-   
Sales per share (Unadj.) Rs198.21,764.8-  
Earnings per share (Unadj.) Rs18.5110.2-  
Cash flow per share (Unadj.) Rs35.0252.9-  
Dividends per share (Unadj.) Rs3.0096.51-  
Dividend yield (eoy) %0.53.4 15.4%  
Book value per share (Unadj.) Rs186.31,960.3-  
Shares outstanding (eoy) m805.70848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.91.6 180.0%   
Avg P/E ratio x31.426.1 120.3%  
P/CF ratio (eoy) x16.611.4 146.2%  
Price / Book Value ratio x3.11.5 212.7%  
Dividend payout %16.287.5 18.5%   
Avg Mkt Cap Rs m468,0312,436,414 19.2%   
No. of employees `00022.644.9 50.4%   
Total wages/salary Rs m28,5650-   
Avg. sales/employee Rs Th7,053.133,297.0 21.2%   
Avg. wages/employee Rs Th1,261.50-   
Avg. net profit/employee Rs Th659.12,080.0 31.7%   
INCOME DATA
Net Sales Rs m159,7101,496,532 10.7%  
Other income Rs m4,7660-   
Total revenues Rs m164,4751,496,532 11.0%   
Gross profit Rs m30,973409,826 7.6%  
Depreciation Rs m13,263120,966 11.0%   
Interest Rs m1,68429,394 5.7%   
Profit before tax Rs m20,791259,466 8.0%   
Minority Interest Rs m-1721,179 -14.6%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-170,325 0.0%   
Tax Rs m5,695-3,168 -179.8%   
Profit after tax Rs m14,92493,487 16.0%  
Gross profit margin %19.427.4 70.8%  
Effective tax rate %27.4-1.2 -2,243.6%   
Net profit margin %9.36.2 149.6%  
BALANCE SHEET DATA
Current assets Rs m124,2661,010,752 12.3%   
Current liabilities Rs m37,715881,462 4.3%   
Net working cap to sales %54.28.6 627.3%  
Current ratio x3.31.1 287.3%  
Inventory Days Days9191 99.8%  
Debtors Days Days9596 98.9%  
Net fixed assets Rs m105,190488,800 21.5%   
Share capital Rs m1,6113,684 43.7%   
"Free" reserves Rs m148,5110-   
Net worth Rs m150,1231,662,364 9.0%   
Long term debt Rs m38,301765,210 5.0%   
Total assets Rs m239,6333,420,056 7.0%  
Interest coverage x13.39.8 135.8%   
Debt to equity ratio x0.30.5 55.4%  
Sales to assets ratio x0.70.4 152.3%   
Return on assets %6.93.6 192.9%  
Return on equity %9.95.6 176.8%  
Return on capital %11.84.9 240.0%  
Exports to sales %34.70-   
Imports to sales %00-   
Net fx Rs m38,3680-   
CASH FLOW
From Operations Rs m16,911238,470 7.1%  
From Investments Rs m-16,687-84,499 19.7%  
From Financial Activity Rs m-3,487-286,061 1.2%  
Net Cashflow Rs m-3,451-132,090 2.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.67 Rs / USD

Compare CIPLA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CIPLA With: BIOCON   WOCKHARDT  SHASUN PHARMA  DR. DATSONS LABS  ELDER PHARMA  



Today's Market

Sensex Trades 138 Points Lower; Dow Futures Down by 124 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 138 points, down 0.3%, at 40,566 levels.

Related Views On News

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CIPLA SHARE PRICE


Oct 22, 2020 02:42 PM

TRACK CIPLA

MORE ON CIPLA

CIPLA 8-QTR ANALYSIS

COMPARE CIPLA WITH

FEATURED VIDEOS

Why ITC and not HUL is my Idea of a Good Investment Right Now

Contrarian Trading in PSU Banks

Why I Asked My Subscribers to Sell Stocks and Move into Cash?

How to Save Money by Exiting Stocks Before They Fall

More Featured Videos

MARKET STATS